Semaglutide research peptide vial

Metabolic Research

Semaglutide

Explore Semaglutide for research online — third-party tested GLP-1 peptide. Explore mechanism of action, purity verification, and research applications.

Catalogue record
OP-976
Intended use
Research use only
Independent COA on this site
Not available

This corporate catalogue does not take orders, display prices or provide dosage instructions.

Research record

Overview

Compound name: Semaglutide

Compound classification: Synthetic peptide; glucagon-like peptide-1 (GLP-1) receptor agonist

Brief factual description:

Semaglutide is a long-acting synthetic analog of human GLP-1 engineered to resist enzymatic degradation and extend plasma half-life. It enhances glucose-dependent insulin secretion, suppresses appetite, and slows gastric emptying, making it effective in the management of type 2 diabetes and obesity.

Mechanism of Action

Primary biological targets: GLP-1 receptor (GLP-1R)

Affected systems: Endocrine, metabolic, gastrointestinal, central nervous system

Receptor selectivity:

High specificity for GLP-1 receptor

Downstream signaling effects:

Glucose-dependent insulin secretion

Suppression of glucagon release

Delayed gastric emptying

Central appetite suppression via hypothalamic pathways

Frequently asked questions

What this record can—and cannot—confirm

Is Semaglutide approved for human use?

Semaglutide is supplied strictly for in-vitro laboratory and research use only, not for human consumption or therapeutic use. Regulatory treatment varies by jurisdiction.

How is the purity of Semaglutide verified?

No independent report for this specific product was available in the public migration source. Request batch-specific documentation from the authorised reseller before relying on a purity claim.

Where can I buy Semaglutide?

Through an OnlinePeptides authorized reseller. Verify any reseller at onlinepeptides.com/verify-reseller/ before purchasing.